Physician profile
Morgan Sigel
NPI 1588308308
$3,896.24
in general payments reported to CMS, 2019-2025
17 companies · $144 in 2025
The $144 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $730 · 2023: $1,412 · 2024: $1,611 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,166.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,309.75 | 2022-2025 | |
| Novo Nordisk INC | $612.24 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Astrazeneca Pharmaceuticals LP | $369.34 | 2022-2024 | Airsupra, Breztri, Farxiga |
| Pfizer INC. | $297.21 | 2022-2024 | |
| Lilly USA, LLC | $265.67 | 2022-2025 | Mounjaro, Jardiance, Emgality |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $238.67 | 2022-2023 | Trulance, Xifaxan |
| Glaxosmithkline, LLC. | $150.20 | 2022-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Biohaven Pharmaceutical Holding Company LTD. | $135.87 | 2022 | |
| Galderma Laboratories, L.P. | $88.26 | 2025 | |
| Exact Sciences Corporation | $87.51 | 2023-2024 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $68.55 | 2024-2025 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $67.02 | 2023-2024 | Eliquis |
| Merck Sharp & Dohme LLC | $65.32 | 2022-2023 | Belsomra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.50 | 2022-2023 | Jardiance |
| Amgen INC. | $38.77 | 2024 | Otezla, Repatha |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $28.69 | 2024 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $16.67 | 2024 | Austedo Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Sigel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.